These compounds may interact with:
Cyclin-T1
Potentially involved in: carcinoma; acquired immunodeficiency syndrome; acute myeloid leukemia; acute quadriplegic myopathy; juvenile dermatomyositis; osteosarcoma; ovarian cancer; pick disease; primary pancreatic ductal adenocarcinoma; psoriasis
Disease data sourced from Pharos.